Urgent Care Valuation Premiums: The Three Levers That Add a Turn of EBITDA

Urgent care centers trade at 3.0x-10.0x EBITDA in 2026. Three levers move you up the ladder: per-center EBITDA, in-network status, provider independence.

By John M. SalonyAugust 24, 2026

Quick Answer

Urgent care centers trade from roughly 3.0x to 10.0x EBITDA in 2026, and three levers decide where you land. Lever one is per-center EBITDA. A single site producing under $400,000 of EBITDA prices at 3.0x to 5.0x because it reads as founder-dependent; two or three sites producing $500,000-plus each read as a strategic add-on and clear 5.0x to 7.0x. Lever two is payer mix with named commercial in-network status. A center at 65% or better commercial payer mix with executed in-network agreements is worth a full turn more than an identical center leaning on self-pay and workers' compensation, because the buyer can model the revenue without renegotiating a single contract. Lever three is provider independence. If your centers run on staffed physicians, nurse practitioners, or physician assistants and a working medical director who is not the selling owner, buyers underwrite continuity. If you personally cover shifts, they underwrite risk and price accordingly. Pull all three and a regional group can support 7.0x to 10.0x as an emerging platform. The active buyers are private-equity-backed platforms including CityMD under Warburg Pincus, GoHealth under TPG, and FastMed under ABRY; strategics such as Optum's MedExpress, HCA's CareNow, and Concentra under Select Medical; plus hospital systems buying centers as outpatient access points. Announced deal count has settled near 29 a year, so buyers are selective. Expect six to ten months to close.

Urgent Care Valuation Premiums: The Three Levers That Add a Turn of EBITDA

Urgent care centers trade from roughly 3.0x to 10.0x EBITDA in 2026, and I can usually tell within one meeting where an owner is going to land. Three levers do almost all the work, and two of them can be fixed in twelve to eighteen months.

The Three Levers

Per-center EBITDA: under $400K reads founder-dependent at 3.0x-5.0x; $500K+ per site reads strategic add-on at 5.0x-7.0x
Named commercial in-network status: 65%+ commercial mix with executed contracts is worth about a full turn
Provider independence: a medical director who is not the seller moves you from risk to continuity
Emerging platform range: 7.0x-10.0x for regional groups pulling all three
Deal volume: roughly 29 announced transactions a year

What Revenue and EBITDA Profile Do Urgent Care Buyers Want?

Buyers underwrite per-center contribution, not consolidated revenue. A group doing $12 million across eight thin centers is worth less than a group doing $8 million across four strong ones, every time. The threshold I watch is $500,000 of EBITDA per site; above that, a buyer can model a return without assuming any operational turnaround, and your file moves from the small-deal pile into the strategic add-on pile.

That is also why de novo expansion right before a sale usually backfires. A new center opened nine months before you go to market drags consolidated EBITDA down while it ramps, and buyers rarely give full credit for projected maturity. If you are within eighteen months of a process, fix the centers you have rather than adding one you cannot season.

How Much Does Payer Mix Affect an Urgent Care Valuation?

More than any other single line item. Two centers with identical visit volume and identical EBITDA will get different offers if one runs 65% commercial with executed in-network agreements and the other leans on self-pay, Medicaid, and workers' compensation. The first buyer inherits contracted rates they can model directly. The second inherits a renegotiation project and prices that risk into the multiple, usually to the tune of a full turn.

Named in-network status matters because platform buyers are buying access, not just EBITDA. If you already hold agreements with the dominant commercial payers in your area, you are a plug-in acquisition. That is the same reason understanding how urgent care buyers build their models before you negotiate is worth more than another quarter of visit growth, and why it pays to know what your centers are actually worth going in.

John's Take

I worked with a three-site urgent care owner who was still covering roughly eight clinical shifts a month himself because he thought it showed commitment. Every buyer we spoke with read it as key-person risk and discounted for it. We hired a full-time medical director, ran twelve months with him out of the schedule, and went back to market. Same revenue, same centers, and the offers came in more than a turn higher. Buyers pay for a business that does not need you, and the fastest way to prove that is to stop being in the building.

Find Out What Your Urgent Care Business Is Worth

Start with the free valuation calculator to see where your per-center economics place you on the multiple ladder. Then schedule a confidential consultation to work through which of the three levers is worth pulling first.

Schedule a Confidential Consultation

Frequently Asked Questions

What revenue and EBITDA profile do urgent care buyers want?

Buyers underwrite per-center contribution rather than consolidated revenue, which surprises owners who have been measuring themselves on the top line. A group doing $12 million across eight thin centers will be valued below a group doing $8 million across four strong ones, essentially every time. The threshold that matters is roughly $500,000 of EBITDA per site. Above it, a buyer can model an acceptable return without assuming any operational turnaround, and your file moves out of the small-deal pile and into the strategic add-on pile where multiples run 5.0x to 7.0x instead of 3.0x to 5.0x. This is also why opening new centers immediately before a sale usually backfires. A de novo location launched nine months before you go to market drags consolidated EBITDA down while it ramps, and buyers rarely give full credit for projected maturity on an unseasoned site. If you are within eighteen months of running a process, put the capital into strengthening the centers you already operate.

How much does payer mix affect an urgent care valuation?

More than any other single line item on the file. Two centers with identical visit volume and identical EBITDA will receive materially different offers if one runs 65% or better commercial payer mix with executed in-network agreements and the other leans on self-pay, Medicaid, and workers' compensation. The first buyer inherits contracted rates they can model directly from day one. The second inherits a renegotiation project with uncertain timing and prices that risk into the multiple, typically costing about a full turn of EBITDA. Named in-network status carries extra weight because platform buyers are acquiring market access, not only earnings. If you already hold agreements with the dominant commercial payers where you operate, you are a plug-in acquisition for CityMD, GoHealth, FastMed, MedExpress, CareNow, or Concentra, and you should be paid for that. Documenting your payer mix by center, with contract effective dates and rate schedules, is one of the highest-return pieces of preparation you can do.

Back to all articles Browse all topics

Find Out What Your Urgent Care Business Is Worth

Start with the free valuation calculator to see where your per-center economics land on the multiple ladder. Then schedule a confidential consultation to decide which lever is worth pulling first and in what order. Nothing is shared with any buyer without your written consent.

100% Confidential